Glioblastoma is very difficult to treat because it quickly adapts and evolves to become resistant to existing treatments indicated for…
Earth Science Tech seeks to implement a unified strategy aimed at maximizing shareholder value, resolving structural hurdles, and elevating corporate…
Researchers from the University of Manchester in the UK have found that a small group of immune cells that aren’t given much…
Regentis has passed 50% enrollment in the pivotal Phase III SAGE study of GelrinC, with recruitment completion targeted for the…
Dozens of global drugmakers are ramping up their investments in the United States in a bid to sidestep the planned tariffs on…
A new Japanese patent allowance follows a recent such US patent grant, strengthens protection around the organic solvent-free manufacturing process…
Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Researchers recognize that a large share of…
Beachgoers on the Gulf Coast in the U.S. have been urged to exercise caution in order to limit the risk of contracting a bacterial infection…
Earth Science Tech, a growing healthcare holding company, recently reported its Q1 2027 financial results, with key highlights including $9.0…
Doctors in Spain recently handled a fascinating yet terrifying case of a patient that developed brain cancer-like symptoms and was treated as such, but additional tests…